Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Research and development spending
3Y CAGR
-12.2%/yr
vs +5.4%/yr prior
5Y CAGR
+12.4%/yr
Recent deceleration
Acceleration
-17.6pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $52.65M | +56.7% |
| 2024 | $33.59M | -65.9% |
| 2023 | $98.38M | +26.4% |
| 2022 | $77.81M | +77.6% |
| 2021 | $43.81M | +49.3% |
| 2020 | $29.34M | -54.8% |
| 2019 | $64.90M | +3.0% |
| 2018 | $63.01M | +58.4% |
| 2017 | $39.79M | +18.9% |
| 2016 | $33.48M | - |